Frank Hazevoets
Chief Executive Officer at DMS IMAGING
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-Paul Ansel | M | 74 | 2 years | |
| Béatrice de Vos | M | - |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | 5 years |
| Vincent Bille | M | - | - | |
| Michel Baijot | M | - | 6 years | |
| François Fontaine | M | - | - | |
| Samuel Sancerni | M | - | - | |
| Philippe Degeer | M | 61 | - | |
| François Meurgey | M | - | 11 years | |
| Philippe Ghem | M | - | - | |
| Martine Draguet | M | - | 10 years | |
| Nathalie Caire Richard | F | - | - | |
| Delphine de Courson | F | - | - | |
| Swan Tuffery | M | - | - | |
| Louise Armengaud | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yves Jean Marie Désiront | M | 53 | 7 years | |
| John Tchelingerian | M | - |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | 5 years |
| Willy W. Duron | M | 79 | - | |
| Jean-Paul Prieels | M | 78 |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | 1 years |
| Dirk Reyn | M | 62 | 5 years | |
| Claudia D'Augusta | M | 54 | 7 years | |
| John Brock | M | 75 |
InBev SA
| 3 years |
| An Moonen | F | - | 8 years | |
| Sven Arne Andréasson | M | 72 | 2 years | |
| Eric Halioua | M | - |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | 6 years |
| Harry Welten | M | 59 | - | |
| Frank P. Luyten | M | 69 | 11 years | |
| Luc Dochez | M | 49 | 5 years | |
| Philippe Degive | M | - |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | - |
| Lawrence J. Macauley | M | - |
InBev SA
| 3 years |
| Charles L. Dimmler | M | 82 |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | 2 years |
| Ilka Wicke | M | - |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | - |
| Gauthier de Biolley | M | - |
InBev SA
| 6 years |
| Michel Naquet-Radiguet | M | 74 |
InBev SA
| 10 years |
| Heico Breek | M | - | 4 years | |
| Jürgen Beck | M | - |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | - |
| Patrick Stragier | M | - |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | 2 years |
| Marleen Johanna Limbourg | M | - | 3 years | |
| Luc van de Steen | M | 62 | 8 years | |
| Luc Missorten | M | 69 |
InBev SA
| 13 years |
| J. André de Barros Teixeira | M | 71 |
InBev SA
| 1 years |
| Andreas Hilger | M | - |
InBev SA
| 6 years |
| Reiko Namikawa | M | 70 |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | - |
| Koenraad Blot | M | 62 | - | |
| Hugo Geoffrey L. Powell | M | 79 |
InBev SA
| 3 years |
| Louis Champion | M | 64 | 2 years | |
| Steven Cahillane | M | 58 |
InBev SA
| 6 years |
| Raf Moons | M | - | - | |
| Masaki Doi | M | - |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | - |
| Luis Felipe Pedreira Dutra Leite | M | 58 |
InBev SA
| - |
| Claudio Moniz Barreto Garcia | M | 55 |
InBev SA
| - |
| Joël Jean-Mairet | M | 52 | 2 years | |
| François M. M. C. Jaclot | M | 75 |
InBev SA
| 3 years |
| Iain John Grant Napier | M | 74 |
InBev SA
| 1 years |
| J. André Teixeira | M | 71 |
InBev SA
| 1 years |
| Marie Pierre Beaumont | F | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Belgium | 55 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Frank Hazevoets
- Personal Network
